Tirzepatide Injection 7.5 mg

Tirzepatide Injection 7.5 mg  is a once-weekly subcutaneous medication used to improve blood sugar control in adults with type 2 diabetes, complementing diet and exercise.

It functions as a dual agonist for glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, enhancing insulin secretion and promoting weight loss. The 2.5 mg dose serves as the initial starting dosage and is not intended for glycemic control; after four weeks, the dosage is typically increased to 5 mg once weekly.

Common side effects include nausea, diarrhea, vomiting, constipation, and abdominal discomfort.

Tirzepatide is contraindicated in individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Consult a healthcare provider before starting tirzepatide to ensure it’s appropriate for your condition.

website : Jyotilifecar

Weight-Loss Medications and GLP-1 Agonists

Original price was: $790.Current price is: $720.

Category: Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,